Literature DB >> 2453977

Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus.

I Correa1, G Jiménez, C Suñé, M J Bullido, L Enjuanes.   

Abstract

The antigenic structure of transmissible gastroenteritis (TGE) virus E2 glycoprotein has been defined at three levels: antigenic sites, antigenic subsites and epitopes. Four antigenic sites (A, B, C and D) were defined by competitive radioimmunoassay (RIA) using monoclonal antibodies (MAbs) selected from 9 fusions. About 20% (197) of the hybridomas specific for TGE virus produced neutralizing MAbs specific for site A, which was one of the antigenically dominant determinants. Site A was differentiated in three antigenic subsites: a, b and c, by characterization of 11 MAb resistant (mar) mutants, that were defined by 8, 3, and 3 MAbs, respectively. These subsites were further subdivided in epitopes. A total of 11 epitopes were defined in E2 glycoprotein, eight of which were critical for virus neutralization. Neutralizing MAbs were obtained only when native virus was used to immunize mice, although to produce hybridomas mice immunizations were made with antigen in the native, denatured, or mixtures of native and denatured form. All neutralizing MAbs reacted to conformational epitopes. The antigenic structure of the E2-glycoprotein has been defined with murine MAbs, but the antigenic sites were relevant in the swine, the natural host of the virus, because porcine sera reacted against these sites. MAbs specific for TGE virus site C reacted to non-immune porcine sera. This reactivity was not directed against porcine immunoglobulins. These results indicated that TGE virus contains epitope(s) also present in some non-immunoglobulin component of porcine serum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453977      PMCID: PMC7134057          DOI: 10.1016/0168-1702(88)90059-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  23 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies.

Authors:  J W Yewdell; A J Caton; W Gerhard
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

4.  Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein.

Authors:  I Seif; P Coulon; P E Rollin; A Flamand
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Critical epitopes in transmissible gastroenteritis virus neutralization.

Authors:  L Enjuanes; I Correa; G Jiménez; M P Melgosa; M J Bullido
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

6.  Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies.

Authors:  M R Stone; R C Nowinski
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

7.  Enumeration of antigenic sites of influenza virus hemagglutinin.

Authors:  D C Jackson; J M Murray; D O White; W U Gerhard
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  A high-performance liquid chromatographic procedure for the purification of mouse monoclonal antibodies.

Authors:  J R Deschamps; J E Hildreth; D Derr; J T August
Journal:  Anal Biochem       Date:  1985-06       Impact factor: 3.365

9.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

10.  Genome of porcine transmissible gastroenteritis virus.

Authors:  D A Brian; D E Dennis; J S Guy
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

View more
  49 in total

Review 1.  Porcine epidemic diarrhea: a review of current epidemiology and available vaccines.

Authors:  Daesub Song; Hyoungjoon Moon; Bokyu Kang
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

2.  Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.

Authors:  Kuo-Ming Lip; Shuo Shen; Xiaoming Yang; Choong-Tat Keng; Aihua Zhang; Hsueh-Ling Janice Oh; Zhi-Hong Li; Le-Ann Hwang; Chih-Fong Chou; Burtram C Fielding; Timothy H P Tan; Josef Mayrhofer; Falko G Falkner; Jianlin Fu; Seng Gee Lim; Wanjin Hong; Yee-Joo Tan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Transgenic mice secreting coronavirus neutralizing antibodies into the milk.

Authors:  I Sola; J Castilla; B Pintado; J M Sánchez-Morgado; C B Whitelaw; A J Clark; L Enjuanes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

6.  Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies.

Authors:  J Castilla; I Sola; L Enjuanes
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Long-distance RNA-RNA interactions in the coronavirus genome form high-order structures promoting discontinuous RNA synthesis during transcription.

Authors:  Pedro A Mateos-Gomez; Lucia Morales; Sonia Zuñiga; Luis Enjuanes; Isabel Sola
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

8.  Passive protection of piglets by recombinant baculovirus induced transmissible gastroenteritis virus specific antibodies.

Authors:  T Tuboly; E Nagy; J B Derbyshire
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

9.  Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.

Authors:  J M Torres; C Alonso; A Ortega; S Mittal; F Graham; L Enjuanes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus.

Authors:  M De Diego; M D Laviada; L Enjuanes; J M Escribano
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.